The DOI matches its Crossref record.
Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
Abstract
This study examined in baboons various behavioral effects of zolpidem, a short-acting imidazopyridine hypnotic which has selectivity for subtypes of the benzodiazepine receptor. Intravenous drug self-injection was studied under a fixed-ratio 80- or 160-response schedule with a 3-hr timeout after each injection. Maximal rates of self-injection maintained by zolpidem (0.01-1 mg/kg) were consistently higher than those maintained by vehicle and the benzodiazepine hypnotic triazolam. Substitution of vehicle after about 2 weeks of zolpidem self-injection (7-8 mg/kg/day) resulted in a time-limited suppression of food pellet intake, indicating a drug withdrawal effect. In a drug discrimination study, baboons were trained to discriminate either lorazepam (1.8 mg/kg p.o.) or pentobarbital (10 mg/kg p.o.) from the no-drug condition. Zolpidem (0.1-18 mg/kg p.o.) occasioned both lorazepam- and pentobarbital-appropriate responding (greater than 80%) in a dose-dependent manner. In a final experiment, zolpidem (3.2 or 5.6 mg/kg i.m.) produced ataxia and sedation that progressively decreased over 7 consecutive days of administration. The withdrawal, discriminative stimulus effects and tolerance shown with zolpidem were similar to those shown previously with benzodiazepines under similar conditions. The rates of self-injection of zolpidem were similar to those maintained by intermediate duration barbiturates (e.g., pentobarbital) and higher than those maintained by 11 benzodiazepines studied previously under similar conditions. Further research on the reinforcing effects of zolpidem may provide useful insights into mechanisms underlying the maintenance of behavior by compounds acting through the benzodiazepine receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using self-administration studies, it was shown that efficacy at α 1-containing GABAA subtypes significantly contributed to the reinforcing effects and withdrawal symptoms of benzodiazepines [8, 28, 29].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [29]
In the citing paper
“Thus, it is important to note that, even though zolpidem does not seem to engender any obvious tolerance development, zolpidem can lead to withdrawal symptoms that are comparable to those seen after chronic classical benzodiazepine treatment [29, 77].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [29]
Citations
Cited by
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
“Physical dependence has developed in nonhuman primates given zolpidem[63-65] (reviewed by Rush[66] and Stephens & Sanger[67]).”
Griffiths, R. R., & Weerts, E. M. (1997) · Psychopharmacology · doi:10.1007/s002130050422 · Cited by 260
Self-citationBehavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review
Rush, C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00102-6 · Cited by 260
Principles of drug abuse liability assessment in laboratory animals
Ator, N. A., & Griffiths, R. R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00099-1 · Cited by 249
“The rationale for methodological choices is supported by citation of the literature; but some rationale inevitably is in terms of our own experience, over more than two decades, with the development, use, and evaluation of procedures for comprehensive abuse liability assessments (Griffiths et al., 1979, 1985; Brady et…”
BackgroundSelf-citationIntracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
Negus, S. S., & Miller, L. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007419 · Cited by 209
“…et al., 2012); however, numerous drug self-administration studies in nonhuman primates have documented reinforcing effects of zolpidem, and zolpidem is currently classified as a schedule 4 compound by the FDA along with most other benzodiazepines (Griffiths et al., 1992; Licata and Rowlett, 2011).”
Background
Metadata
- Authors
- Griffiths, R. R., Sannerud, C. A., Ator, N. A., & Brady, J. V.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1992-03
- Volume
- 260
- Issue
- 3
- Pages
- 1199-1208
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2290279581
- Cited by
- 112
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 6
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01da001147-28)
- U.S. Public Health Service (271-86-8113)
- National Institute on Drug Abuse (R01 DA01147, R01DA004133)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- zolpidem, benzodiazepine receptor, self-injection, drug discrimination, drug tolerance, withdrawal, reinforcement effect, barbiturates, lorazepam, pentobarbital, ataxia, sedation, baboons
- MeSH terms
- Zolpidem, Animals, Barbiturates, Cocaine, Discrimination Learning, Drug Tolerance, Hypnotics and Sedatives, Male, Papio, Pyridines, Receptors, GABA-A, Reinforcement, Psychology, Self Administration, Substance Withdrawal Syndrome, Triazolam, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. https://app.cochat.ai/papers/10.1016/s0022-3565(25)11429-8
- The paper
- Griffiths, R. R., Sannerud, C. A., Ator, N. A., & Brady, J. V. (1992). Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)11429-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.